EP
Highly rated in
13
conditions
Highly rated in
13
conditions
Check Dr. Elizabeth A. Poplin's experience treating your condition:
About Dr. Elizabeth A. Poplin

Elizabeth Poplin is an Oncologist and a Palliative Medicine expert in New Brunswick, New Jersey. Poplin has been practicing medicine for over 47 years and is highly rated in 13 conditions, according to our data. Her top areas of expertise are Colorectal Cancer, Appendix Cancer, Pancreatic Cancer, and Familial Colorectal Cancer. She is licensed to treat patients in New Jersey. Poplin is currently accepting new patients.

Her clinical research consists of co-authoring 24 peer reviewed articles and participating in 8 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Elizabeth A. Poplin it is best to call her office and ask if your insurance is accepted.

Accepts Medicare

Dr. Elizabeth A. Poplin accepts the following insurance:

  •  Ambetter

Call to see if your plan is accepted.
Locations
195 Little Albany St, New Brunswick, NJ 08901
Background & Education
Graduate Institution
University Of Massachusetts Medical School, 1976
Specialties
Oncology
Palliative Medicine
Licenses
Internal Medicine in NJ
Hospital Affiliations
Robert Wood Johnson University Hospital New Brunswick
Languages Spoken
English
Gender
Female
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


7 Clinical Trials

Phase II Pilot Study of FOLFOXIRI Plus Panitumumab in Metastatic RAS Wild-type, Left-sided Colorectal Cancer
A Phase II Study of MLN0128 (TAK-228) in Rapalog-Resistant Advanced Pancreatic Neuroendocrine Tumors (PNET)
Phase II Study of Imatinib Mesylate and Gemcitabine for First-line Treatment of Metastatic Pancreatic Cancer
View 6 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors